Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 5Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Multiple Myeloma 2Digestive System Neoplasms 2Digestive System Diseases 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Stomatitis 1Rectal Diseases 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Intestinal Neoplasms 1Intestinal Diseases 1Inflammation 1Graft vs Host Disease 1Gliosarcoma 1

Interventions

Temozolomide 115Bevacizumab 72Radiotherapy 52Radiation 23Erlotinib Hydrochloride 13Lomustine 12pembrolizumab 11Magnetic Resonance Spectroscopy 11Vorinostat 10Nivolumab 10Surgical Procedures, Operative 9Irinotecan 9Sorafenib 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 7Immunoglobulin G 7Everolimus 7Drug Therapy 7Disulfides 7Radiosurgery 6Granulocyte-Macrophage Colony-Stimulating Factor 6Carmustine 6antineoplaston AS 2-1 5antineoplaston A10 5Sirolimus 5Cilengitide 5veliparib 4veledimex 4temsirolimus 4selinexor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Glioblastoma × Ascorbic Acid × Clear all
NCT02168270 2023-11-24

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

University of Nebraska

Phase 1 Terminated
4 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡